Skip to main content
Erschienen in: Endocrine 3/2020

10.08.2020 | COVID-19 | Review Zur Zeit gratis

Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review

verfasst von: Giuseppe Lisco, Anna De Tullio, Vito Angelo Giagulli, Edoardo Guastamacchia, Giovanni De Pergola, Vincenzo Triggiani

Erschienen in: Endocrine | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Epidemiological data suggest that comorbid patients, mostly those with type 2 diabetes (T2D), are predisposed to poor prognosis in Coronavirus disease 2019 (COVID-19), leading to serious healthcare concerns. The aim of the present manuscript is to review the main relevant mechanisms possibly contributing to worsen the clinical course of COVID-19 in T2D.

Results

Poor glucose control, high glycaemic variability and diabetes-related comorbidities at baseline, particularly cardiovascular diseases and obesity, contribute in worsening the prognosis in the above-mentioned cluster of patients. Moreover, both a lower efficient innate immune system response and cytokine dysregulation predispose patients with T2D to impaired viral clearance and more serious pulmonary and systemic inflammation once the SARS-CoV-2 infection occurred. Inconclusive data are currently available for specifically indicate or contraindicate concurrent medications for managing T2D and its comorbidities in infected patients.

Conclusions

T2D individuals should be considered as more vulnerable to COVID-19 than general population, and thus require adequate advices about hygienic tips to protect themselves during the pandemic. A careful management of glucose levels and diabetes-related comorbidities remains essential for avoiding further complications, and patient monitoring during the pandemic should be performed also at distance by means of telemedicine. Further studies are needed to clarify whether medications normally used for managing T2D and its associated comorbidities could have a protective or detrimental effect on COVID-19 clinical course.
Literatur
43.
Zurück zum Zitat N. Chow, K. Fleming-Dutra, R. Gierke et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. Morb. Mortal. Wkly Rep. 69(13), 382–386 (2020). https://doi.org/10.15585/mmwr.mm6913e2CrossRef N. Chow, K. Fleming-Dutra, R. Gierke et al. Preliminary estimates of the prevalence of selected underlying health conditions among patients with coronavirus disease 2019—United States, February 12–March 28, 2020. Morb. Mortal. Wkly Rep. 69(13), 382–386 (2020). https://​doi.​org/​10.​15585/​mmwr.​mm6913e2CrossRef
77.
Zurück zum Zitat P. Sarzi-Puttini, V. Giorgi, S. Sirotti et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin. Exp. Rheumatol. 38(2), 337–342 (2020)PubMed P. Sarzi-Puttini, V. Giorgi, S. Sirotti et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin. Exp. Rheumatol. 38(2), 337–342 (2020)PubMed
121.
131.
Zurück zum Zitat I.D. van Koeverden, M. de Bakker, S. Haitjema et al. Testosterone to oestradiol ratio reflects systemic and plaque inflammation and predicts future cardiovascular events in men with severe atherosclerosis. 115(2), 453–462 (2019). https://doi.org/10.1093/cvr/cvy188 I.D. van Koeverden, M. de Bakker, S. Haitjema et al. Testosterone to oestradiol ratio reflects systemic and plaque inflammation and predicts future cardiovascular events in men with severe atherosclerosis. 115(2), 453–462 (2019). https://​doi.​org/​10.​1093/​cvr/​cvy188
136.
Zurück zum Zitat W. Zhang, C. Li, B. Liu et al. Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis. Ann. Hepatol. 12(6), 892–900 (2013)CrossRefPubMed W. Zhang, C. Li, B. Liu et al. Pioglitazone upregulates hepatic angiotensin converting enzyme 2 expression in rats with steatohepatitis. Ann. Hepatol. 12(6), 892–900 (2013)CrossRefPubMed
141.
Zurück zum Zitat A.J. Garber, Y. Handelsman, G. Grunberger et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm-2020 executive summary. Endocr. Pract. 26(1), 107 (2020). https://doi.org/10.4158/CS-2019-0472CrossRefPubMed A.J. Garber, Y. Handelsman, G. Grunberger et al. Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm-2020 executive summary. Endocr. Pract. 26(1), 107 (2020). https://​doi.​org/​10.​4158/​CS-2019-0472CrossRefPubMed
165.
Zurück zum Zitat M. Bengaluru Jayanna, J.G. Robinson, The extent to which statins have improved cardiovascular outcomes: Lessons from randomized trials and observational studies of “real world” practice in people with diabetes. Diabetes Obes. Metab. 21(S1), 17–27 (2019). https://doi.org/10.1111/dom.13701CrossRefPubMed M. Bengaluru Jayanna, J.G. Robinson, The extent to which statins have improved cardiovascular outcomes: Lessons from randomized trials and observational studies of “real world” practice in people with diabetes. Diabetes Obes. Metab. 21(S1), 17–27 (2019). https://​doi.​org/​10.​1111/​dom.​13701CrossRefPubMed
181.
Zurück zum Zitat M. Nacoti, A. Ciocca, A. Giupponi et al. At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catalyst innovations in care delivery (2020). https://doi.org/10.1056/CAT.20.0080 M. Nacoti, A. Ciocca, A. Giupponi et al. At the epicenter of the Covid-19 pandemic and humanitarian crises in Italy: changing perspectives on preparation and mitigation. NEJM Catalyst innovations in care delivery (2020). https://​doi.​org/​10.​1056/​CAT.​20.​0080
184.
Metadaten
Titel
Hypothesized mechanisms explaining poor prognosis in type 2 diabetes patients with COVID-19: a review
verfasst von
Giuseppe Lisco
Anna De Tullio
Vito Angelo Giagulli
Edoardo Guastamacchia
Giovanni De Pergola
Vincenzo Triggiani
Publikationsdatum
10.08.2020
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 3/2020
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02444-9

Weitere Artikel der Ausgabe 3/2020

Endocrine 3/2020 Zur Ausgabe

Praxisempfehlungen der Deutschen Diabetes Gesellschaft

Kurz, prägnant und aktuell: Die Praxisempfehlungen der Deutschen Diabetes Gesellschaft. 

Passend zum Thema

ANZEIGE

IPD-Fallzahlen & Pneumokokken-Impfung bei Kindern in Deutschland

Das Niveau der postpandemischen Fallzahlen für invasive Pneumokokken-Erkrankungen (IPD) ist aus Sicht des Referenz-Zentrums für Streptokokken in Aachen alarmierend [1]. Wie sich die monatlichen IPD-Fallzahlen bei Kindern und Jugendlichen von Juli 2015 bis März 2023 entwickelt haben, lesen Sie hier.

ANZEIGE

HPV-Impfung: Auch für junge Erwachsene sinnvoll und wichtig

Auch nach dem 18. Lebensjahr kann eine HPV-Impfung sinnvoll und wichtig sein. Viele gesetzliche Krankenkassen übernehmen die Kosten auch zu einem späteren Zeitpunkt noch.

ANZEIGE

Impfstoffe – Krankheiten vorbeugen, bevor sie entstehen

Seit mehr als 130 Jahren entwickelt und produziert MSD Impfstoffe für alle Altersgruppen. Hier finden Sie nützliche Informationen und Praxismaterialien rund um das Thema Impfen.

MSD Sharp & Dohme GmbH